DROGALSKI LTD

Company number 13595407 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

DROGALSKI LTD - Analysis Report

Company Number: 13595407

Analysis Date: 2025-07-20 14:30 UTC

Financial Health Assessment for DROGALSKI LTD


1. Financial Health Score: C

  • Explanation: The company shows signs of basic financial viability with positive net assets and profitability, but the scale of operations and cash flow vitality is weak, indicating moderate financial health. The small turnover and declining current assets signal potential vulnerability if not addressed.

2. Key Vital Signs

Metric 2024 Value (£) Interpretation
Turnover 14,342 Very low revenue for a trading company, indicating limited sales activity.
Profit for Period 339 Marginal profit, showing the company is barely breaking even.
Current Assets 727 Low cash and receivables balance, indicating limited liquidity.
Current Liabilities 80 Low short-term debts, manageable relative to assets.
Net Current Assets 647 Positive working capital, indicating enough short-term resources to cover liabilities.
Net Assets (Shareholders’ Funds) 647 Positive equity, but very small, suggesting low capital buffer.
Staff Costs 1,906 Low staff costs consistent with likely a single employee/director.
Other Charges 12,017 High other expenses relative to turnover, reducing profitability.
Average Number of Employees 1 Business appears to be a sole proprietorship or micro-business.

Additional Notes:

  • The company is classified as a Micro entity, subject to limited filing requirements.
  • The turnover decreased from £22,097 (2023) to £14,342 (2024), indicating a drop in business activity.
  • Profit dropped significantly from £6,413 to £339, suggesting rising costs or shrinking margins.
  • Current assets reduced from £1,848 to £727, showing a weakening liquidity position.
  • Current liabilities decreased from £1,540 to £80, suggesting better short-term debt control.

3. Diagnosis

DROGALSKI LTD exhibits symptoms of financial fragility typical of very small startup or micro businesses. The "vital signs" reflect:

  • Healthy cash flow is lacking: The low levels of current assets and turnover indicate limited cash inflows.
  • Symptoms of distress include declining turnover and profit margins, and a shrinking asset base.
  • The company appears to maintain positive working capital, which is a good sign, but the scale is minimal and could quickly be eroded.
  • The reliance on one employee (the director) and the high proportion of "other charges" suggest fixed overhead pressures relative to income.
  • The business has a thin equity cushion, meaning it could be vulnerable to unexpected expenses or economic downturns.
  • No indications of overdue filings or legal complications, which is positive.
  • Overall, the company resembles a "micro-level patient" with stable but fragile financial health requiring close monitoring.

4. Recommendations

To strengthen financial wellness and improve prognosis, DROGALSKI LTD should consider the following actions:

  1. Boost Revenue Streams

    • Explore new clients or expand services to increase turnover.
    • Review pricing strategy and marketing to enhance sales volume.
  2. Cost Management

    • Scrutinize and reduce "other charges" as these are disproportionately high relative to turnover.
    • Optimize operational expenses without compromising service quality.
  3. Improve Liquidity

    • Enhance cash collection processes to increase current assets.
    • Maintain disciplined control over payables to avoid liquidity crunches.
  4. Build Capital Reserves

    • Consider capital injection or retained earnings to increase net assets and buffer against downturns.
    • This will improve financial resilience and ability to invest in growth.
  5. Financial Monitoring

    • Regularly track key metrics such as cash flow, profitability, and working capital.
    • Set early warning indicators to detect financial stress promptly.
  6. Strategic Planning

    • Develop a medium-term business plan focusing on sustainable growth and profitability.
    • Leverage the director’s management and accounting expertise (SIC codes: management consultancy and accounting) to optimize business model.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.